The groundbreaking approach of the medication represents a significant breakthrough in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide855168.tblogz.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-55222782